Discontinuation report ZANTAC

Last updated on 2017-09-19 History
Report ID 22614
Drug Identification Number 02212358
Brand name ZANTAC
Common or Proper name Ranitidine tablets
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size All pack sizes / Tous les formats
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-09-14
Remaining supply date 2018-05-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-09-19 French Compare
v1 2017-09-19 English Compare

Showing 1 to 2 of 2